MYLAN LABORATORIES LTD

MYLAN LABORATORIES LTD (India)

Nature of Business: Factory (Manufacturer)

Company Introduction:

Mylan Laboratories Ltd in India is a significant manufacturing and research and development arm of Viatris Inc., a global healthcare company formed through the combination of Mylan and Upjohn (a division of Pfizer). Mylan Laboratories Ltd primarily operates as a large-scale manufacturer of active pharmaceutical ingredients (APIs), finished dosage forms (FDFs), and various other pharmaceutical products. It plays a crucial role in Viatris's global supply chain, producing a wide range of generic and branded generic medicines for infectious diseases, cardiovascular conditions, oncology, and more. The company has extensive manufacturing facilities in India, adhering to international quality standards and contributing substantially to the global pharmaceutical market. It is a major employer and a key player in India's pharmaceutical manufacturing sector.

Mylan Laboratories Ltd, operating in India, manufactured and sold a broad portfolio of generic, specialty, and over-the-counter pharmaceutical products across numerous therapeutic areas.

Their product range included:

Antiretrovirals for HIV/AIDS treatment, such as Efavirenz, Tenofovir, Lamivudine, Dolutegravir, and various fixed-dose combinations.

Oncology products, including chemotherapeutic agents like Paclitaxel, Doxorubicin, Gemcitabine, and Capecitabine.

Cardiovascular medications, such as Metoprolol, Atorvastatin, Amlodipine, Valsartan, and Ramipril.

Central Nervous System drugs, including Gabapentin, Pregabalin, Sertraline, and Venlafaxine.

Gastroenterology products like Omeprazole, Pantoprazole, and Rabeprazole.

Pain management and anti-inflammatory medications, such as Ibuprofen, Naproxen, and Diclofenac.

Respiratory treatments, including Salbutamol and Montelukast.

Dermatology products, anti-infectives, and medicines for women's health.

The company also had a significant presence in biosimilars, offering products such as Trastuzumab (marketed as Ogivri), Adalimumab, and Pegfilgrastim.

Mylan also produced and distributed a variety of other generic medicines covering a wide spectrum of medical conditions.